alpha-aminopyridine has been researched along with Lymphoma, Non-Hodgkin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 8 (61.54) | 2.80 |
| Authors | Studies |
|---|---|
| Alinari, L; Baiocchi, RA; Benson, D; Blum, KA; Bond, DA; Christian, BA; Cohen, JB; Huang, Y; Jaglowski, S; Maddocks, KJ | 1 |
| Dong, T; Jing, F; Song, W; Wang, L; Wang, Y; Xiao, S; Xue, H | 1 |
| Chen, R; Ding, K; Hu, M; Li, J; Li, Y; Liang, J; Shen, H; Wang, L; Wu, J; Xia, Y; Xu, W; Yin, H; Zhu, H | 1 |
| Grommes, C; Kaley, T; Mellinghoff, IK; Nolan, CP; Panageas, KS; Pentsova, E; Reiner, AS; Schaff, LR | 1 |
| Dou, L; Guan, W; Jing, Y; Wang, M; Xiao, Y; Yu, L | 1 |
| Hu, S; Wang, W; Zhang, W; Zhang, Y; Zhou, D; Zou, D | 1 |
| Mitamura, K; Miyake, K; Nishiyama, Y; Norikane, T; Yamamoto, Y | 1 |
| Chen, X; Dong, T; Ji, J; Kuang, P; Li, J; Liu, J; Liu, T; Liu, Z; Shen, K; Zhang, C; Zhang, L | 1 |
| Barca, EG; Barrigon, DC; Bociek, RG; Gerecitano, J; Kim, WS; Kong, O; Martinelli, G; Pisal, CB; Salles, G; Tavorath, R; Turgut, M; Younes, A | 1 |
| Chumduri, C; Daniel, PT; Gillissen, B; Müller, A; Richter, A; Scholz, CW | 1 |
| Chen, J; Cheng, C; He, MX; Yang, D; Yang, JM; Zhang, WP | 1 |
| Bari, A; Civallero, M; Cosenza, M; Ferri, P; Pozzi, S; Sacchi, S | 1 |
| Cripe, LD; De Vos, S; Friedberg, JW; Gregory, SA; Johnston, PB; Lacasce, A; Leonard, JP; Levy, R; Lowe, AM; Schaefer-Cutillo, J; Sharman, J; Shipp, MA; Sinha, R; Sterba, MP; Sweetenham, J; Vose, JM | 1 |
5 trial(s) available for alpha-aminopyridine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
A phase I study of rituximab and buparlisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma, Non-Hodgkin; Morpholines; Rituximab | 2022 |
Chidamide-BEAC plus autologous stem cell transplantation in high-risk non-Hodgkin lymphoma: a phase II clinical trial.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Transplantation, Autologous | 2023 |
A new conditioning regimen with chidamide, cladribine, gemcitabine and busulfan significantly improve the outcome of high-risk or relapsed/refractory non-Hodgkin's lymphomas.
Topics: Adolescent; Adult; Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Busulfan; Cladribine; Deoxycytidine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Transplantation Conditioning; Transplantation, Autologous; Young Adult | 2021 |
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Recurrence; Remission Induction; Salvage Therapy | 2017 |
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents; Cohort Studies; Diarrhea; Disease-Free Survival; Female; Hematologic Diseases; Humans; Hypertension; Intracellular Signaling Peptides and Proteins; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Morpholines; Neoplasm Proteins; Oxazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Salvage Therapy; Syk Kinase; Treatment Outcome | 2010 |
8 other study(ies) available for alpha-aminopyridine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B-Cell lymphoma -results of a single center, retrospective cohort in China.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Etoposide; Frail Elderly; Histone Deacetylase Inhibitors; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prednisone; Retrospective Studies; Rituximab | 2022 |
Preclinical and clinical evaluation of Buparlisib (BKM120) in recurrent/refractory Central Nervous System Lymphoma.
Topics: Aminopyridines; Central Nervous System; Chronic Disease; Humans; Lymphoma, Non-Hodgkin; Neoplasm Recurrence, Local; Phosphatidylinositol 3-Kinases; Prospective Studies | 2023 |
Chidamide in combination with chemotherapy in refractory and relapsed T lymphoblastic lymphoma/leukemia.
Topics: Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Humans; Lymphoma, Non-Hodgkin; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2020 |
Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report.
Topics: Aged; Aminopyridines; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Female; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Salvage Therapy | 2020 |
Increased Uptake of 18F-THK5351 in Glioblastoma But Not in Primary Central Nervous System Lymphoma.
Topics: Aminopyridines; Central Nervous System; Glioblastoma; Humans; Lymphoma, Non-Hodgkin; Methionine; Positron-Emission Tomography; Quinolines | 2021 |
Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-Hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53.
Topics: Aminopyridines; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Death; Cell Line; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Cyclin B1; Flow Cytometry; Humans; Immunoblotting; Lymphoma, Non-Hodgkin; Mitosis; Morpholines; Phosphatidylinositol 3-Kinases; Polyploidy; Tumor Suppressor Protein p53 | 2018 |
Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report.
Topics: Aminopyridines; Antineoplastic Agents; Benzamides; Diagnosis, Differential; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Skin Neoplasms; Stomach Neoplasms | 2018 |
Activity of BKM120 and BEZ235 against Lymphoma Cells.
Topics: Aminopyridines; Antineoplastic Agents; Autophagy; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Imidazoles; Lymphoma, Non-Hodgkin; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Prognosis; Quinolines; Reactive Oxygen Species; Signal Transduction | 2015 |